PACB News and Press, Pacific Biosciences of California Inc. From 04/21/23

2023-04-21 18:34:12 ET Summary Pacific Biosciences of California, Inc.'s Revio long-read sequencing system is poised to enable large-scale research projects with increased efficiency. The commercial launch of the Revio platform, alongside the ongoing beta testing of the Onso bench...

PacBio to Report First Quarter 2023 Financial Results on May 2, 2023 PR Newswire MENLO PARK, Calif. , April 18, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its first quarter 2023 financial ...

PacBio Announces New Nanobind Extraction Kits to Enable High-Throughput Workflows with Revio and Sequel Systems PR Newswire Kits Combine the Power of HiFi Sequencing and Nanobind Technology to Optimize Sample Preparation Workflows for High Volume Customers MENLO Park...

2023-03-31 13:52:15 ET Pacific Biosciences of California Inc ( NASDAQ: PACB ) is trading meaningfully up on Friday after a TD Cowen analyst turned super bullish on the biotechnology company. Pacific Biosciences stock has upside to $15 Dan Brennan now rates the said biotech s...

2023-03-31 09:22:21 ET Cowen has upgraded PacBio to buy from hold saying that the biotech's present management is leading "a growth transformation story." The firm upped its target price to $15 from $13 (~5.4% upside based on Thursday's close). Shares are up ~8% in premark...

PacBio and Corteva Agriscience Enable Groundbreaking Plant and Microbial Long-Read Sequencing Workflow on Revio System PR Newswire MENLO PARK, Calif. , March 28, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate ...

PacBio Announces a New Informatics Analysis Method for Highly Homologous Genes PR Newswire Paraphase Enables Researchers to Analyze Genes That are Critically Relevant but Hard to Genotype MENLO PARK, Calif. , March 14, 2023 /PRNewswire/ -- PacBio (NAS...

2023-03-07 07:43:31 ET PacBio ( NASDAQ: PACB ) announced the first customer shipments of Revio long-read sequencing systems, featuring significant advances in SMRT Cell design, compute, and system architecture, will commence on Mar.8, 2023. Together, this enables...

PacBio To Begin Commercial Shipment of Revio Systems PR Newswire Broad Commercialization and Scale-Up of Revio Enables Researchers with 15 Times More HiFi Data and High-Quality Human Genomes for Under $1,000 MENLO PARK, Calif. , March 7, 2023 /PRNewsw...

PacBio to Present at Cowen's 43rd Annual Health Care Conference PR Newswire MENLO PARK, Calif. , Feb. 27, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be partic...